Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments.

Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments.

Author:

Khambati A, Wright RE 3rd, Das S, Pasula S, Sepulveda A, Hernandez F, Kanwar M, Chandrasekar P, Kumar A.

Date: 22 June 2022

Abstract:

Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus species, Aspergillus fumigatus, continues to be more prevalent in fungal endophthalmitis patients. However, due to overlapping clinical symptoms with other endophthalmitis etiology, fungal endophthalmitis pose a challenge in its diagnosis and treatment. Hence, it is critical to understand its pathobiology to develop and deploy proper therapeutic interventions for combating Aspergillus infections. This review highlights the different modes of Aspergillus transmission and the host immune response during endophthalmitis. Additionally, we discuss recent advancements in the diagnosis of fungal endophthalmitis. Finally, we comprehensively summarize various antifungal regimens and surgical options for the treatment of Aspergillus endophthalmitis.

Keywords: Aspergillus; antifungal; diagnosis; fungal endophthalmitis; pathogenesis.

Link to DOI

Download the full article (Disclaimer)

This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.